CJC-1295 5 mg + Ipamorelin 5mg

Description

CJC-1295 + Ipamorelin is a synergistic combination of two research peptides: CJC-1295 (DAC-free), a GHRH analog, and Ipamorelin, a selective GH secretagogue. This combination is being studied for its optimal effects on the pulsatile release of growth hormone.

Composition

• CJC-1295 (without DAC): 5 mg — Extended-release GHRH analogue
• Ipamorelin: 5 mg — Selective GH secretagogue with no effect on cortisol

Total: 10 mg per vial

Experimental exhibition (research)

• Research exposure: 100–300 mcg of each peptide
• Synergy studied on the GH/IGF-1 axis
• For use exclusively in controlled scientific environments

Informative benefits (research)

• Studies on the pulsatile release of GH
• Research on body recomposition
• Analysis of deep sleep quality
• Potential improvement in muscle recovery
• Studies on skin, collagen and tissues
• Research on cellular longevity

For research use only - Not intended for human consumption.